SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chandan Healthcare Ltd (CHANDAN)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: CHANDAN Hospital & Healthcare Services | Small Cap | Chandan Healthcare Share Price

BSE Share Price
Not Listed

Chandan Healthcare Ltd (CHANDAN)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: CHANDAN Hospital & Healthcare Services | Small Cap | Chandan Healthcare Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹608 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹10.4
TTM Sales
₹157 Cr.
Book Value per Share
₹68
P/E Ratio
23.98
Lower than its 5-year historical median
Industry PE
93.9
Price to Book (P/B)
3.65
Lower than its 5-year historical median
Price to Sales (P/S)
3.88
Lower than its 5-year historical median
EV/EBITDA
12.73
Lower than its 5-year historical median
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
25.75%
Outperforms industry median
Return on Capital Employed (ROCE)
28.38%
Outperforms industry median
Return on Assets (ROA)
15.39%
Operating Profit Margin
28.5%
Net Profit Margin
16.09%
Gross Profit Margin
26.8%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
29.33%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
44.85%
Net Profit Growth (1 Year)
-
29.71%
Asset Quality
Promoter Holding
49.55%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹142 Cr.
Equity
₹24.5 Cr.
Face Value
₹10
All Time Low / High
- / -

Chandan Healthcare stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

Somewhat Undervalued

Price Trend

Semi Strong
Q.1 Is Chandan Healthcare Ltd a good quality company?
Chandan Healthcare Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Chandan Healthcare Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Chandan Healthcare Ltd vs industry peers?
Chandan Healthcare Ltd revenue CAGR is 21.73%, compared to the industry median CAGR of 6.53%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Chandan Healthcare Ltd?
Promoters hold 49.55% of the Chandan Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Valuation ratios of Chandan Healthcare Ltd vs historical?
The current P/E ratio of 27.68 is lower than its historical median of 29.81, indicating that the stock is trading below its historical average valuation.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Chandan Healthcare Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 5.4%18.1%40.9%28.4%-
Value Creation
Index
-0.60.31.91.0-

Growth Parameters

Sales 71.675.899.9129157
Sales YoY Gr.-5.9%31.7%29.3%-
Adj EPS -0.5288.510.4
YoY Gr.-NA296.5%6.1%-
BVPS (₹) 11.313.320.349.468
Adj Net
Profit
-141620.825
Cash Flow from Ops. 08.75.9-18.7-
Debt/CF from Ops. 01.95-1.8-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANA21.7%29.3%
Adj EPS NANANA6.1%
BVPSNANA63.5%142.8%
Share Price - - - 24.9%

Key Financial Parameters

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-4.316.447.625.817.7
Op. Profit
Mgn %
5.312.325.528.526.6
Net Profit
Mgn %
-1.45.31616.116.2
Debt to
Equity
0.70.60.70.30.2
Working Cap
Days
010511217297
Cash Conv.
Cycle
0-4246364

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales7276100129
Operating Expenses + 68677492
Manufacturing Costs21181822
Material Costs12224
Employee Cost 14203033
Other Costs 21272433
Operating Profit 492537
Operating Profit Margin (%) 5.3%12.3%25.5%28.5%
Other Income + 0011
Exceptional Items 0000
Interest 2224
Depreciation 2236
Profit Before Tax -052128
Tax 1157
Profit After Tax -141621
PAT Margin (%) -1.3%5.3%16.0%16.1%
Adjusted EPS (₹)-0.52.08.08.5
Dividend Payout Ratio (%)-108.70%49.50%18.70%0%

Valuation of Chandan Healthcare - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 232741121
Share Capital 20202024
Reserves 372196
Debt +12142326
Long Term Debt781222
Short Term Debt56114
Minority Interest0000
Trade Payables817610
Others Liabilities 17122320
Total Liabilities 597093177

Fixed Assets

Net Fixed Assets +25284471
Gross Block535877111
Accumulated Depreciation28303440
CWIP 0004
Investments 14151310
Inventories10617
Trade Receivables10162231
Cash Equivalents 2216
Others Assets 79837
Total Assets 597093177

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 096-19
PBT 052128
Adjustment 05510
Changes in Working Capital 0-1-17-49
Tax Paid 0-1-4-7
Cash Flow From Investing Activity + 0-6-15-36
Capex 0-5-19-38
Net Investments 0-132
Others 0010
Cash Flow From Financing Activity + 0-2960
Net Proceeds from Shares 00062
Net Proceeds from Borrowing 0-0410
Interest Paid 0-2-2-3
Dividend Paid 00-2-3
Others 0-08-6
Net Cash Flow 01-15

Financial Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-4.0716.4147.5925.75
ROCE (%)5.4418.140.8528.38
Asset Turnover Ratio1.21.171.230.96
PAT to CFO Conversion(x)N/A2.250.38-0.9
Working Capital Days
Receivable Days53.2063.406975.10
Inventory Days6.303.8012.5033.30
Payable Days233.102,619.601,873.20702.80

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Chandan Healthcare Ltd FAQs

The current trading price of Chandan Healthcare on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Chandan Healthcare stood at ₹607.6 Cr

The latest P/E ratio of Chandan Healthcare as of 31-Dec-1969 is 23.98.

The latest P/B ratio of Chandan Healthcare as of 31-Dec-1969 is 3.65.

The 52-week high of Chandan Healthcare is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Chandan Healthcare is ₹157 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Chandan Healthcare Ltd is a below average quality company.

The key valuation ratios of Chandan Healthcare Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Chandan Healthcare Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Chandan Healthcare Ltd

Chandan Healthcare was incorporated as a public limited Company under the name ‘Chandan Healthcare Limited’, under the provisions of the Companies Act, 1956 and Certificate of Incorporation was issued by the Registrar of Companies, U.P. & Uttaranchal, Kanpur on September 03, 2003. The company runs a diagnostic network in North India with pathology and radiology testing services. It has flagship laboratory, central laboratories, satellite centres, and collection centres. It provides a wide range of tests across different specialties. Its test menu includes (a) routine pathology tests, covering basic biochemistry and hematology, as well as specialized pathology tests, such as immohistopathology, and molecular pathology, and (b) radiology tests, including basic x-rays, ultrasonography (USG), computed tomography (CT), magnetic resonance imaging (MRI), and specialized CT scans.

The company has adopted a clusters and collection points model i.e. grouping of nearby patients or laboratories or clinics into clusters and collecting samples at those designated points, then transporting them in bulk to a central laboratory for processing, this enhances its economies of scale, ensures greater consistency in testing procedures, and boosts its brand presence by reaching more customers in remote areas. Samples are collected from various locations within a cluster and transported to its laboratories for diagnostic testing. Each diagnostic centres provides integrated diagnostics services (pathology and radiology tests under one roof) with small and medium centres offering pathology tests and basic and intermediate radiology tests, and large centres offering pathology tests, basic and advanced radiology tests.

The company primarily provides diagnostic services; however, it also does ad hoc sale of its consumables like X-ray films, reagents for laboratory testing and other consumables necessary for healthcare operations to its group companies. Its subsidiary, Chandan Pharmacy, is engaged in the business of operating medical stores, offering a wide range of pharmaceutical products including medical consumables such as tablets, capsules, syrups, ointments, and a variety of dosage forms, including liquids, solids, and semisolids. It also provides essential items like injectables and inhalers to meet the diverse healthcare needs of its customers.

Business area of the company

The company is specialized in operating state-of-the-art laboratories that offer comprehensive pathological investigations. Its services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provides an extensive array of radiology services, including CT scans, X-rays, and MRIs.

Services of the company

  • Routine Diagnostics (169 tests)
  • Specialised Tests (713 tests) 
  • Preventive Health Packages 
  • Routine Imaging 
  • Specialised Imaging
  • Preventive Imaging

History and milestones

  • 2003: Incorporation of the company in the name style of ’Chandan Healthcare Limited.
  • 2003: Started its first diagnostic centre in Indra Nagar Lucknow.
  • 2013: Started its first diagnostic centre in Dehradun.
  • 2023: Crossed turnover of Rs 75 crore.
  • 2024: Surpassed turnover of Rs 150 crore and broadened presence with new diagnostic centres.
  • 2025: Listed on the stock exchange and achieved turnover of Rs 200 crore. 
  • 2025: Entered new geographies including Rajasthan and Bihar, with expansion plans into Delhi, Raipur, and Bhopal.

You have 4 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: